Physician profile
Henry Dorn
NPI 1811053762
$424.20
in general payments reported to CMS, 2019-2025
9 companies · $50.42 in 2025
The $50.42 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.41 · 2020: $18.43 · 2022: $50.80 · 2023: $55.92 · 2024: $151 · 2025: $50.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.85 | 2024 | Wegovy |
| Hologic Sales and Service, LLC | $60.26 | 2022-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Merck Sharp & Dohme LLC | $50.33 | 2019-2020 | |
| Organon LLC | $49.79 | 2022-2023 | Nexplanon |
| Shield Therapeutics INC | $45.64 | 2023-2024 | Accrufer |
| Pfizer INC. | $30.82 | 2025 | |
| Roche Diagnostics Corporation | $24.61 | 2019 | |
| Ethicon US, LLC | $21.41 | 2019 | |
| Mission Pharmacal Company | $19.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Dorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.